Search Results for 'drug study'

drug study published presentations and documents on DocSlides.

Switch
Switch
by lindy-dunigan
from. TDF to TAF. GS-US-292-0109 Study. GS-US-31...
Kohlberg and Gilligan Study
Kohlberg and Gilligan Study
by lindy-dunigan
By : Beth Cline . Kohlberg . Lived 1927-1987. Fro...
Sentencing Research / Sentencing Practice
Sentencing Research / Sentencing Practice
by liane-varnes
Frank O. Bowman, III. Floyd R. Gibson Missouri En...
Inpatient
Inpatient
by lois-ondreau
. treatment. and . recovery. . process. of . ...
ASPIRE Class 5
ASPIRE Class 5
by myesha-ticknor
Biostatistics and Data Collection Tools. Daniel M...
Clinical Trials
Clinical Trials
by alexa-scheidler
in . Pediatric Neurology. Aaron S. Zelikovich. Ob...
Aprepitant
Aprepitant
by stefany-barnette
Lau Man . Kuen. (14), . Tang . Tsz. . Ching. (...
Meta-Analysis of Clinical Data for Regulated Biopharmaceuti
Meta-Analysis of Clinical Data for Regulated Biopharmaceuti
by min-jolicoeur
Answers to Frequently Asked Questions. Brenda Cro...
Plan Ahead – Minimizing the Risk of Pediatric Medication
Plan Ahead – Minimizing the Risk of Pediatric Medication
by pasty-toler
Errors. Implications for Disaster Medicine . Will...
Statistical issues:
Statistical issues:
by conchita-marotz
Designing your trial for success. Elizabeth Garre...
Clinical Research Staff/Coordinator
Clinical Research Staff/Coordinator
by giovanna-bartolotta
Roles . &. Responsibilities. Sue Collins, MS...
ATYPICAL ANTIPSYCHOTIC
ATYPICAL ANTIPSYCHOTIC
by phoebe-click
CLOZAPINE. BY: PATRIZIA ORLANDO. CLOZAPINE. Cloza...
STUDY DESIGN AND EFFICIENCY
STUDY DESIGN AND EFFICIENCY
by alida-meadow
MfD. . – Wednesday 23rd . January . 2013. Ioan...
Costa Mesa: A Case Study
Costa Mesa: A Case Study
by test
Regulating Sober Living Homes In Residential Zone...
Overview of NPN Session
Overview of NPN Session
by phoebe-click
Submitted by . Courtney Dowell, MPH, CHES. Breako...
How to collect the data you need
How to collect the data you need
by alexa-scheidler
Designing experiments. OUTLINE of topics. Avoid o...
HIV Pre-Exposure Prophylaxis (
HIV Pre-Exposure Prophylaxis (
by cheryl-pisano
PrEP. ). Yuma Health District 5/23/16. Alyssa Gui...
Childhood Trauma: Essential Information
Childhood Trauma: Essential Information
by myesha-ticknor
for Courts. 2015 WATCP CONFERENCE. March 26. th....
New Drug Update 2016 A Formulary Approach
New Drug Update 2016 A Formulary Approach
by test
J. Russell May, Pharm.D., FASHP. Clinical Profess...
Ethics Forum: VIOXX   Marco Acevedo, Andrew Adams, Leah Ali, Safi
Ethics Forum: VIOXX Marco Acevedo, Andrew Adams, Leah Ali, Safi
by aaron
Ayinde. , Loren Ball . Dr. Jeffrey . Evanseck. Ju...
Dabigatran in  myocardial injury after noncardiac
Dabigatran in myocardial injury after noncardiac
by lois-ondreau
surgery. Dr. PJ Devereaux on behalf of . MANAGE I...
ADHD Medication The next “pill to pop”
ADHD Medication The next “pill to pop”
by calandra-battersby
Attention deficit . Hyper-Activity disorder. Orig...
Clinical Research Staff/Coordinator
Clinical Research Staff/Coordinator
by natalia-silvester
Roles . &. Responsibilities. Sue Collins, MS...
Penicillin  Katelyn Fields, Candy Lu, Neda Maleki, and Maya Reddy
Penicillin Katelyn Fields, Candy Lu, Neda Maleki, and Maya Reddy
by karlyn-bohler
History and Evolution . Discovered in London in S...
Clinical  Management Module
Clinical Management Module
by stefany-barnette
4. . (b) . Risks and Side Effects. Overview. Res...
W orking  with  Different Groups
W orking with Different Groups
by briana-ranney
Module 3 (f). People who Inject Drugs. People who...
New Drugs 2018 The Good, The Bad, & The Worthless
New Drugs 2018 The Good, The Bad, & The Worthless
by liane-varnes
Bill Origer MD. Disclosure. No commercial financi...
Ethics Forum: VIOXX   Marco Acevedo, Andrew Adams, Leah Ali, Safi
Ethics Forum: VIOXX Marco Acevedo, Andrew Adams, Leah Ali, Safi
by yoshiko-marsland
Ayinde. , Loren Ball . Dr. Jeffrey . Evanseck. Ju...
Self-Study Modules  on Tuberculosis, 1-5
Self-Study Modules on Tuberculosis, 1-5
by test
Centers for Disease Control and Prevention. Divis...
Long-term Tolerability and Efficacy of Evolocumab (AMG 145) in
Long-term Tolerability and Efficacy of Evolocumab (AMG 145) in
by pamella-moone
Hyperlipidemic. Subjects: A 52 Week Phase 3 Dou...
Reimagining Pharmacist Scope of Practice
Reimagining Pharmacist Scope of Practice
by min-jolicoeur
Krystalyn Weaver, PharmD. VP, Policy & Operat...
RESISTANT HYPERTENSION OR POOR PATIENT ADHERENCE?
RESISTANT HYPERTENSION OR POOR PATIENT ADHERENCE?
by kittie-lecroy
TIPS TO GAIN CONTROL. HTN Burden of Disease. Impo...
Self-Study Modules  on Tuberculosis
Self-Study Modules on Tuberculosis
by mitsue-stanley
Treatment of Latent . Tuberculosis Infection and ...
Ethics Forum: VIOXX   Marco Acevedo, Andrew Adams, Leah Ali, Safi
Ethics Forum: VIOXX Marco Acevedo, Andrew Adams, Leah Ali, Safi
by yoshiko-marsland
Ayinde. , Loren Ball . Dr. Jeffrey . Evanseck. Ju...
Meta-Analysis of Clinical Data for Regulated Biopharmaceutical Products:  
Meta-Analysis of Clinical Data for Regulated Biopharmaceutical Products:  
by cheryl-pisano
Answers to Frequently Asked Questions. Brenda Cro...
ART Initiation:  PrEP  and
ART Initiation: PrEP and
by alida-meadow
Treatment-naïve Patients . Clinical Instructor, ...
Seminar I: Chapter  5 Funding dilemma
Seminar I: Chapter 5 Funding dilemma
by lindy-dunigan
Mohd. Nasir . Ayob. , Le Fu, Oscar Janson, Natas...
Where do they go? Destination Unknown: An exploratory study of the disposal of transdermal drug pat
Where do they go? Destination Unknown: An exploratory study of the disposal of transdermal drug pat
by stefany-barnette
L Breenª, H Zaman, A Mahmood, W Nabi, F . Mansoo...
Safety of the Subject  Cena Jones-Bitterman, MPP, CIP, CCRP
Safety of the Subject Cena Jones-Bitterman, MPP, CIP, CCRP
by natalia-silvester
Holden Comprehensive Cancer Center. Protocol Deve...